Soft Tissue Sarcoma Research Report 2019-2026
Increasing prevalence of soft tissue sarcoma, rising Research and Development activities on drugs and other therapies, are some of the growth factors boosting the growth of the market. Soft tissue sarcoma is a type of cancer that grows from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. There are around 50 different types of soft tissue sarcoma, such as adult fibrosarcoma, angiosarcoma, clear cell sarcoma, alveolar soft-part sarcoma, kaposi sarcoma, malignant mesenchymoma, rhabdomyosarcoma, and others. There are several drugs used for the treatment of soft tissue sarcoma such as sunitinib (sutent), trabectedin (yondelis), sirolimus (rapamune), bevacizumab (avastin), doxorubicin (adriamycin), and others. ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-soft-tissue-sarcomamarketsize-share-value-and-competitive-landscape-2021---2026-2021-06-14 In Oct 2016, U.S. Food and Drug Administration approved Eli Lilly and Company’...